Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-6,170
Closed -$17K 4098
2017
Q1
$17K Sell
6,170
-5,749
-48% -$14.6K ﹤0.01% 3770
2016
Q4
$27K Sell
11,919
-74
-0.6% -$218 ﹤0.01% 4058
2016
Q3
$42K Buy
11,993
+6,485
+118% +$29.7K ﹤0.01% 4033
2016
Q2
$74K Buy
5,508
+3,026
+122% +$50.3K ﹤0.01% 4103
2016
Q1
$40K Sell
2,482
-1,523
-38% -$20.8K ﹤0.01% 3906
2015
Q4
$64K Buy
4,005
+629
+19% +$10.8K ﹤0.01% 4122
2015
Q3
$48K Sell
3,376
-3,431
-50% -$58.1K ﹤0.01% 4181
2015
Q2
$152K Buy
+6,807
New +$170K ﹤0.01% 4309
2015
Q1
Sell
-8,288
Closed -$136K 4824
2014
Q4
$136K Buy
8,288
+3,776
+84% +$58.9K ﹤0.01% 4376
2014
Q3
$69K Sell
4,512
-3,834
-46% -$75.8K ﹤0.01% 4338
2014
Q2
$209K Sell
8,346
-2,660
-24% -$60.6K ﹤0.01% 4326
2014
Q1
$230K Buy
+11,006
New +$391K ﹤0.01% 4281

Other funds holding CYTR

Credit Suisse's CYTR Position: Q2 2017 in Review

Credit Suisse sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 6,170 shares — an estimated $17K sold.

Credit Suisse first reported a position in CYTR in Q1 2014 and held it in 12 quarters. The position peaked at $230K in Q1 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

  • Credit Suisse reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
  • Credit Suisse sold 6,170 CytRx Corp shares in Q2 2017, an estimated $17K.
  • Credit Suisse first reported a position in CytRx Corp in Q1 2014 and held it in 12 quarters.
  • Credit Suisse's CytRx Corp position peaked at $230K in Q1 2014.
  • 54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.